Protective effect of doxycycline use on coronary artery disease?
about
Activator protein-1 (AP-1) signalling in human atherosclerosis: results of a systematic evaluation and intervention studyThe effect of prolonged systemic doxycycline therapy on serum tissue degrading proteinases in coronary bypass patients: a randomized, double-masked, placebo-controlled clinical trial.Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease.
P2860
Protective effect of doxycycline use on coronary artery disease?
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 19 September 2005
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Protective effect of doxycycline use on coronary artery disease?
@en
Protective effect of doxycycline use on coronary artery disease?
@nl
type
label
Protective effect of doxycycline use on coronary artery disease?
@en
Protective effect of doxycycline use on coronary artery disease?
@nl
prefLabel
Protective effect of doxycycline use on coronary artery disease?
@en
Protective effect of doxycycline use on coronary artery disease?
@nl
P2093
P1433
P1476
Protective effect of doxycycline use on coronary artery disease?
@en
P2093
Athanasia Papazafiropoulou
Chrysanthos Petropoulos
Marina Kardara
Paraskevi Katsakiori
P304
P356
10.1016/J.JINF.2005.07.003
P577
2005-09-19T00:00:00Z